| EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction M Oelke, A Bachmann, A Descazeaud, M Emberton, S Gravas, MC Michel, ... European urology 64 (1), 118-140, 2013 | 1475 | 2013 |
| EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction C Gratzke, A Bachmann, A Descazeaud, MJ Drake, S Madersbacher, ... European urology 67 (6), 1099-1109, 2015 | 1110 | 2015 |
| The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction C D'Ancona, B Haylen, M Oelke, L Abranches‐Monteiro, E Arnold, ... Neurourology and urodynamics 38 (2), 433-477, 2019 | 634 | 2019 |
| Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel … M Oelke, F Giuliano, V Mirone, L Xu, D Cox, L Viktrup European urology 61 (5), 917-925, 2012 | 414 | 2012 |
| EAU Guidelines on benign prostatic hyperplasia (BPH) JJ de la Rosette, G Alivizatos, S Madersbacher, M Perachino, D Thomas, ... European urology 40 (3), 256-263, 2001 | 413 | 2001 |
| Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume M Oelke, K Höfner, U Jonas, JJ De la Rosette, DT Ubbink, H Wijkstra European urology 52 (3), 827-835, 2007 | 320 | 2007 |
| A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment B Peyronnet, E Mironska, C Chapple, L Cardozo, M Oelke, ... European urology 75 (6), 988-1000, 2019 | 306 | 2019 |
| Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis M Gacci, G Corona, L Vignozzi, M Salvi, S Serni, C De Nunzio, A Tubaro, ... BJU international 115 (1), 24-31, 2015 | 299 | 2015 |
| Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign … TRW Herrmann, T Bach, F Imkamp, A Georgiou, M Burchardt, M Oelke, ... World journal of urology 28, 45-51, 2010 | 256 | 2010 |
| Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia M Oelke, J Baard, H Wijkstra, JJ de la Rosette, U Jonas, K Höfner European urology 54 (2), 419-426, 2008 | 256 | 2008 |
| Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men M Oelke, K Höfner, B Wiese, V Grünewald, U Jonas World journal of urology 19, 443-452, 2002 | 226 | 2002 |
| Guidelines on the management of male lower urinary tract symptoms (LUTS), incl M Oelke, A Bachmann, A Descazeaud, M Emberton, S Gravas, MC Michel, ... Benign Prostatic Obstruction (BPO). European Association of Urology, 45-48, 2012 | 203 | 2012 |
| Immunohistochemical distribution of cAMP-and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate S Ückert, M Oelke, CG Stief, KE Andersson, U Jonas, P Hedlund European urology 49 (4), 740-745, 2006 | 183 | 2006 |
| Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus … M Oelke, K Becher, D Castro-Diaz, E Chartier-Kastler, M Kirby, A Wagg, ... Age and ageing 44 (5), 745-755, 2015 | 181 | 2015 |
| Detrusor underactivity: a plea for new approaches to a common bladder dysfunction GA Van Koeveringe, B Vahabi, KE Andersson, R Kirschner‐Herrmans, ... Neurourology and urodynamics 30 (5), 723-728, 2011 | 181 | 2011 |
| Is the use of parasympathomimetics for treating an underactive urinary bladder evidence‐based? MM Barendrecht, M Oelke, MP Laguna, MC Michel BJU international 99 (4), 749-752, 2007 | 180 | 2007 |
| Ultrasound measurement of detrusor wall thickness in healthy adults M Oelke, K Höfner, U Jonas, D Ubbink, J de la Rosette, H Wijkstra Neurourology and Urodynamics: Official Journal of the International …, 2006 | 179 | 2006 |
| The underactive bladder: a new clinical concept? CR Chapple, NI Osman, L Birder, GA van Koeveringe, M Oelke, VW Nitti, ... European urology 68 (3), 351-353, 2015 | 175 | 2015 |
| Latest evidence on the use of phosphodiesterase type 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia M Gacci, KE Andersson, C Chapple, M Maggi, V Mirone, M Oelke, H Porst, ... European urology 70 (1), 124-133, 2016 | 149 | 2016 |
| Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms C Füllhase, C Chapple, JN Cornu, C De Nunzio, C Gratzke, SA Kaplan, ... European urology 64 (2), 228-243, 2013 | 149 | 2013 |
